More than 170 million people in North and South America have sleep apnea, according to a new study released today by apnea device-maker ResMed (NYSE:RMD). The company reached the 170 million figure based on the American Academy of Sleep Medicine (AASM) 2012 criteria and termed it a “conservative” estimate. The figure represents 37% of adults […]
